Cover Image for Nucleate TAU presents: Pizza & Innovation with Prof. Ronit Satchi-Fainaro
Cover Image for Nucleate TAU presents: Pizza & Innovation with Prof. Ronit Satchi-Fainaro
Nucleate is a free, trainee-led 501(c)(3) non-profit organization dedicated to empowering the next generation of biotech leaders.
53 Went

Nucleate TAU presents: Pizza & Innovation with Prof. Ronit Satchi-Fainaro

Registration
Past Event
Welcome! To join the event, please register below.
About Event

Pizza 🍕 & Innovation with Prof. Ronit Satchi-Fainaro 💡

Join us for an inspiring event ✨ where we’ll explore the intersection of groundbreaking science and real-world impact 🚀.

We’re thrilled to host Prof. Ronit Satchi-Fainaro 👩‍🔬, a global leader in nanomedicine, cancer research, and academic entrepreneurship. She will share her incredible journey of transforming cutting-edge science into tangible solutions, detailing how a breakthrough idea can successfully move from the lab bench to the biotech market.

This is the perfect study break to fuel your brain 🧠 (and your appetite! 😋). Bring your curiosity, grab a slice of pizza 🍕, and learn how to turn your own ambition into action.

About Prof. Ronit Satchi-Fainaro

Ronit Satchi-Fainaro is a full Professor and the head of the Gray School of Medical Sciences at Tel Aviv University. She is the Head of the Cancer Research & Nanomedicine Laboratory, Director of the Cancer Biology Research Center, and Director of the TAU Kahn 3D-BioPrinting Initiative. She has authored over 170 publications, 13 book chapters, edited 2 books, is named inventor on 95 patents, some of which were licensed to Pharmaceutical and Biotech companies, founded 3 spin-off companies, and initiated 2 clinical trials. She is actively engaged in translational research with several industry partners and in science outreach.

Location
Mitchel New Students Union Building
Chaim Levanon St, Tel Aviv-Yafo, 6910301, Israel
Floor -1
Nucleate is a free, trainee-led 501(c)(3) non-profit organization dedicated to empowering the next generation of biotech leaders.
53 Went